AI assistant
Glenmark Pharmaceuticals ltd — Call Transcript 2022
Aug 17, 2022
62608_rns_2022-08-17_5502daa4-58ff-4076-8900-129b3ce0f50f.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [33 x 32] intentionally omitted <==
==> picture [148 x 45] intentionally omitted <==
August 17, 2022
To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 532296
Ref: Scrip Name: GLENMARK
Dear Sirs,
Sub: Transcript of the Earnings Call
Further to our letter dated 01st August, 2022 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, August 12, 2022 for the quarter - ended June 30, 2022 has been uploaded on the Company’s website at https://glenmark.b cdn.net/gpl_pdfs/investors/reports_presentations/earning_concall/Glenmark%20Pharmace uticals-Earnings%20Call%20FY22-23-%20Transcript-12-Aug-2022.pdf
Request you to kindly take the same on record.
Thanking you.
Yours faithfully,
For Glenmark Pharmaceuticals Limited
HARISH Digitally signed by HARISH VINAYA VINAYAK KUBER Date: 2022.08.17 K KUBER 10:57:39 +05'30'
Harish Kuber
Company Secretary & Compliance Officer
Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)
Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: [email protected]